Picture
SEARCH
What are you looking for?
Need help finding what you are looking for? Contact Us
Compare
Free Samples
Healthcare IT

PUBLISHER: Fairfield Market Research | PRODUCT CODE: 1398838

Cover Image

PUBLISHER: Fairfield Market Research | PRODUCT CODE: 1398838

Digital Therapeutics Market - Global Digital Therapeutics Market Industry Analysis, Size, Share, Growth, Trends, Regional Outlook, and Forecast 2023-2030 - (By Application Coverage, By End User Coverage, By Geographic Coverage and By Company)

PUBLISHED:
PAGES: 191 Pages
DELIVERY TIME: 2-5 business days
REQUEST FREE SAMPLE
REQUEST CUSTOMIZATION
SELECT AN OPTION
PPT Slides/PDF & Excel (Enterprise License)
USD 4995

Add to Cart

Description

Table of Contents

The global digital therapeutics market is on track to achieve remarkable growth, with projections indicating that it will surge from US$5.6 billion in 2022 to a substantial US$24.5 billion by the end of 2030. This dynamic market is anticipated to experience a robust compound annual growth rate (CAGR) of 23.5% during the period from 2023 to 2030.

Key Market Trends

  • Healthcare Industry Demand: A significant trend driving the growth of digital therapeutics is the increasing demand from the healthcare industry. These innovative solutions are being embraced due to their effectiveness, scalability, and personalization, ultimately leading to market expansion.
  • Rising Incidence of Preventable Chronic Diseases: The market is witnessing growth driven by the rising incidence of preventable chronic diseases. Digital therapeutics offer cost-effective, personalized interventions for conditions such as diabetes and heart disease, addressing the need to reduce the burden of these diseases and improve population health.
  • Diabetes Applications Lead: Diabetes applications dominate the digital therapeutics market due to the high global prevalence of diabetes. These digital therapeutics provide effective tools for diabetes management, offering personalized interventions, real-time monitoring, and lifestyle guidance.
  • Patient-Centric Care: Patients have secured the largest market share in the digital therapeutics market due to their increasing involvement in self-managing health and their preference for personalized, convenient, and accessible digital solutions. The shift towards patient-centric care has solidified their prominence in the market.

Key Growth Drivers

  • Increasing Emphasis on Preventive Healthcare: Digital therapeutics are benefiting from the growing emphasis on preventive healthcare. These solutions enable personalized, data-driven interventions to manage health proactively, reducing the risk of chronic diseases.
  • Cost-Control Needs: With healthcare expenditures escalating globally, digital therapeutics offer a cost-effective alternative to traditional treatments. They reduce the need for expensive interventions and hospitalizations by focusing on prevention, early intervention, and remote monitoring.

Major Challenges

  • Lack of Awareness: The lack of awareness presents a significant challenge in the digital therapeutics market, hampering adoption rates among patients, healthcare providers, and payers. Education and awareness campaigns are crucial to bridge this gap.
  • Unstable Payment Models: Unstable payment models can hinder market growth. The reimbursement landscape for digital therapeutics is evolving, leading to inconsistent and fragmented payment models.

Regional Highlights

  • North America Leads: North America dominates the digital therapeutics market due to its advanced healthcare infrastructure, robust digital health ecosystem, and favorable reimbursement policies. A strong emphasis on research and development accelerates adoption in this region.
  • Asia Pacific Accelerates: The Asia Pacific region is expected to witness the fastest growth in the global digital therapeutics market. Rising healthcare expenditures, increasing smartphone penetration, and growing awareness of preventive healthcare are driving adoption.

Competitive Landscape

The global digital therapeutics market is consolidated, with key players focusing on new product introductions and distribution channel enhancement to expand their global presence. Further consolidation is expected in the coming years.

Leading Companies in the Global Digital Therapeutics Space

  • Pear Therapeutics
  • Akili Interactive Labs
  • Click Therapeutics
  • Omada Health
  • WellDoc
  • Propeller Health
  • 2Morrow
  • Hinge Health
  • Canary Health
  • Better Therapeutics
  • Kaia Health
  • DarioHealth
  • Mindstrong Health
  • Biofourmis
  • Ginger

Global Digital Therapeutics Market is Segmented as Below:

By Application:

  • Diabetes
  • Obesity
  • CVD
  • Smoking Cessation
  • CNS Diseases
  • OTHERS

By End User:

  • Providers
  • Payers
  • Employers
  • Other

By Geographic Coverage:

  • North America
    • U.S.
    • Canada
  • Europe
    • Germany
    • U.K.
    • France
    • Italy
    • Turkey
    • Russia
    • Rest of Europe
  • Asia Pacific
    • China
    • Japan
    • South Korea
    • India
    • Southeast Asia
    • Rest of Asia Pacific
  • Latin America
    • Brazil
    • Mexico
    • Argentina
    • Rest of Latin America
  • Middle East & Africa
    • GCC
    • South Africa
    • Egypt
    • Nigeria
    • Rest of the Middle East & Africa
Show more

Table of Contents

1. Executive Summary

  • 1.1. Global Digital Therapeutics Market Snapshot
  • 1.2. Future Projections
  • 1.3. Key Market Trends
  • 1.4. Regional Snapshot, by Value, 2022
  • 1.5. Analyst Recommendations

2. Market Overview

  • 2.1. Market Definitions and Segmentations
  • 2.2. Market Dynamics
    • 2.2.1. Drivers
    • 2.2.2. Restraints
    • 2.2.3. Market Opportunities
  • 2.3. Value Chain Analysis
  • 2.4. Porter's Five Forces Analysis
  • 2.5. COVID-19 Impact Analysis
    • 2.5.1. Supply
    • 2.5.2. Demand
  • 2.6. Impact of Ukraine-Russia Conflict
  • 2.7. Economic Overview
    • 2.7.1. World Economic Projections
  • 2.8. PESTLE Analysis

3. Global Digital Therapeutics Market Outlook, 2018 - 2030

  • 3.1. Global Digital Therapeutics Market Outlook, by Application, Value (US$ Bn), 2018 - 2030
    • 3.1.1. Key Highlights
      • 3.1.1.1. Diabetes
      • 3.1.1.2. Obesity
      • 3.1.1.3. CVD
      • 3.1.1.4. Smoking Cessation
      • 3.1.1.5. CNS Diseases
      • 3.1.1.6. Others
  • 3.2. Global Digital Therapeutics Market Outlook, by End User, Value (US$ Bn), 2018 - 2030
    • 3.2.1. Key Highlights
      • 3.2.1.1. Patients
      • 3.2.1.2. Providers
      • 3.2.1.3. Payers
      • 3.2.1.4. Employers
      • 3.2.1.5. Other End users
  • 3.3. Global Digital Therapeutics Market Outlook, by Region, Value (US$ Bn), 2018 - 2030
    • 3.3.1. Key Highlights
      • 3.3.1.1. North America
      • 3.3.1.2. Europe
      • 3.3.1.3. Asia Pacific
      • 3.3.1.4. Latin America
      • 3.3.1.5. Middle East & Africa

4. North America Digital Therapeutics Market Outlook, 2018 - 2030

  • 4.1. North America Digital Therapeutics Market Outlook, by Application, Value (US$ Bn), 2018 - 2030
    • 4.1.1. Key Highlights
      • 4.1.1.1. Diabetes
      • 4.1.1.2. Obesity
      • 4.1.1.3. CVD
      • 4.1.1.4. Smoking Cessation
      • 4.1.1.5. CNS Diseases
      • 4.1.1.6. Others
  • 4.2. North America Digital Therapeutics Market Outlook, by End User, Value (US$ Bn), 2018 - 2030
    • 4.2.1. Key Highlights
      • 4.2.1.1. Patients
      • 4.2.1.2. Providers
      • 4.2.1.3. Payers
      • 4.2.1.4. Employers
      • 4.2.1.5. Other End users
    • 4.2.2. BPS Analysis/Market Attractiveness Analysis
  • 4.3. North America Digital Therapeutics Market Outlook, by Country, Value (US$ Bn), 2018 - 2030
    • 4.3.1. Key Highlights
      • 4.3.1.1. U.S. Digital Therapeutics Market, by Application, Value (US$ Bn), 2018 - 2030
      • 4.3.1.2. U.S. Digital Therapeutics Market, by End User, Value (US$ Bn), 2018 - 2030
      • 4.3.1.3. Canada Digital Therapeutics Market, by Application, Value (US$ Bn), 2018 - 2030
      • 4.3.1.4. Canada Digital Therapeutics Market, by End User, Value (US$ Bn), 2018 - 2030
    • 4.3.2. BPS Analysis/Market Attractiveness Analysis

5. Europe Digital Therapeutics Market Outlook, 2018 - 2030

  • 5.1. Europe Digital Therapeutics Market Outlook, by Application, Value (US$ Bn), 2018 - 2030
    • 5.1.1. Key Highlights
      • 5.1.1.1. Diabetes
      • 5.1.1.2. Obesity
      • 5.1.1.3. CVD
      • 5.1.1.4. Smoking Cessation
      • 5.1.1.5. CNS Diseases
      • 5.1.1.6. Others
  • 5.2. Europe Digital Therapeutics Market Outlook, by End User, Value (US$ Bn), 2018 - 2030
    • 5.2.1. Key Highlights
      • 5.2.1.1. Patients
      • 5.2.1.2. Providers
      • 5.2.1.3. Payers
      • 5.2.1.4. Employers
      • 5.2.1.5. Other End users
    • 5.2.2. BPS Analysis/Market Attractiveness Analysis
  • 5.3. Europe Digital Therapeutics Market Outlook, by Country, Value (US$ Bn), 2018 - 2030
    • 5.3.1. Key Highlights
      • 5.3.1.1. Germany Digital Therapeutics Market, by Application, Value (US$ Bn), 2018 - 2030
      • 5.3.1.2. Germany Digital Therapeutics Market, by End User, Value (US$ Bn), 2018 - 2030
      • 5.3.1.3. U.K. Digital Therapeutics Market, by Application, Value (US$ Bn), 2018 - 2030
      • 5.3.1.4. U.K. Digital Therapeutics Market, by End User, Value (US$ Bn), 2018 - 2030
      • 5.3.1.5. France Digital Therapeutics Market, by Application, Value (US$ Bn), 2018 - 2030
      • 5.3.1.6. France Digital Therapeutics Market, by End User, Value (US$ Bn), 2018 - 2030
      • 5.3.1.7. Italy Digital Therapeutics Market, by Application, Value (US$ Bn), 2018 - 2030
      • 5.3.1.8. Italy Digital Therapeutics Market, by End User, Value (US$ Bn), 2018 - 2030
      • 5.3.1.9. Turkey Digital Therapeutics Market, by Application, Value (US$ Bn), 2018 - 2030
      • 5.3.1.10. Turkey Digital Therapeutics Market, by End User, Value (US$ Bn), 2018 - 2030
      • 5.3.1.11. Russia Digital Therapeutics Market, by Application, Value (US$ Bn), 2018 - 2030
      • 5.3.1.12. Russia Digital Therapeutics Market, by End User, Value (US$ Bn), 2018 - 2030
      • 5.3.1.13. Rest of Europe Digital Therapeutics Market, by Application, Value (US$ Bn), 2018 - 2030
      • 5.3.1.14. Rest of Europe Digital Therapeutics Market, by End User, Value (US$ Bn), 2018 - 2030
    • 5.3.2. BPS Analysis/Market Attractiveness Analysis

6. Asia Pacific Digital Therapeutics Market Outlook, 2018 - 2030

  • 6.1. Asia Pacific Digital Therapeutics Market Outlook, by Application, Value (US$ Bn), 2018 - 2030
    • 6.1.1. Key Highlights
      • 6.1.1.1. Diabetes
      • 6.1.1.2. Obesity
      • 6.1.1.3. CVD
      • 6.1.1.4. Smoking Cessation
      • 6.1.1.5. CNS Diseases
      • 6.1.1.6. Others
  • 6.2. Asia Pacific Digital Therapeutics Market Outlook, by End User, Value (US$ Bn), 2018 - 2030
    • 6.2.1. Key Highlights
      • 6.2.1.1. Patients
      • 6.2.1.2. Providers
      • 6.2.1.3. Payers
      • 6.2.1.4. Employers
      • 6.2.1.5. Other End users
    • 6.2.2. BPS Analysis/Market Attractiveness Analysis
  • 6.3. Asia Pacific Digital Therapeutics Market Outlook, by Country, Value (US$ Bn), 2018 - 2030
    • 6.3.1. Key Highlights
      • 6.3.1.1. China Digital Therapeutics Market, by Application, Value (US$ Bn), 2018 - 2030
      • 6.3.1.2. China Digital Therapeutics Market by End User, Value (US$ Bn), 2018 - 2030
      • 6.3.1.3. Japan Digital Therapeutics Market, by Application, Value (US$ Bn), 2018 - 2030
      • 6.3.1.4. Japan Digital Therapeutics Market, by End User, Value (US$ Bn), 2018 - 2030
      • 6.3.1.5. South Korea Digital Therapeutics Market, by Application, Value (US$ Bn), 2018 - 2030
      • 6.3.1.6. South Korea Digital Therapeutics Market, by End User, Value (US$ Bn), 2018 - 2030
      • 6.3.1.7. India Digital Therapeutics Market, by Application, Value (US$ Bn), 2018 - 2030
      • 6.3.1.8. India Digital Therapeutics Market, by End User, Value (US$ Bn), 2018 - 2030
      • 6.3.1.9. Southeast Asia Digital Therapeutics Market, by Application, Value (US$ Bn), 2018 - 2030
      • 6.3.1.10. Southeast Asia Digital Therapeutics Market, by End User, Value (US$ Bn), 2018 - 2030
      • 6.3.1.11. Rest of Asia Pacific Digital Therapeutics Market, by Application, Value (US$ Bn), 2018 - 2030
      • 6.3.1.12. Rest of Asia Pacific Digital Therapeutics Market, by End User, Value (US$ Bn), 2018 - 2030
    • 6.3.2. BPS Analysis/Market Attractiveness Analysis

7. Latin America Digital Therapeutics Market Outlook, 2018 - 2030

  • 7.1. Latin America Digital Therapeutics Market Outlook, by Application, Value (US$ Bn), 2018 - 2030
    • 7.1.1. Key Highlights
      • 7.1.1.1. Diabetes
      • 7.1.1.2. Obesity
      • 7.1.1.3. CVD
      • 7.1.1.4. Smoking Cessation
      • 7.1.1.5. CNS Diseases
      • 7.1.1.6. Others
  • 7.2. Latin America Digital Therapeutics Market Outlook, by End User, Value (US$ Bn), 2018 - 2030
    • 7.2.1. Key Highlights
      • 7.2.1.1. Patients
      • 7.2.1.2. Providers
      • 7.2.1.3. Payers
      • 7.2.1.4. Employers
      • 7.2.1.5. Other End users
    • 7.2.2. BPS Analysis/Market Attractiveness Analysis
  • 7.3. Latin America Digital Therapeutics Market Outlook, by Country, Value (US$ Bn), 2018 - 2030
    • 7.3.1. Key Highlights
      • 7.3.1.1. Brazil Digital Therapeutics Market, by Application, Value (US$ Bn), 2018 - 2030
      • 7.3.1.2. Brazil Digital Therapeutics Market, by End User, Value (US$ Bn), 2018 - 2030
      • 7.3.1.3. Mexico Digital Therapeutics Market, by Application, Value (US$ Bn), 2018 - 2030
      • 7.3.1.4. Mexico Digital Therapeutics Market, by End User, Value (US$ Bn), 2018 - 2030
      • 7.3.1.5. Argentina Digital Therapeutics Market, by Application, Value (US$ Bn), 2018 - 2030
      • 7.3.1.6. Argentina Digital Therapeutics Market, by End User, Value (US$ Bn), 2018 - 2030
      • 7.3.1.7. Rest of Latin America Digital Therapeutics Market, by Application, Value (US$ Bn), 2018 - 2030
      • 7.3.1.8. Rest of Latin America Digital Therapeutics Market, by End User, Value (US$ Bn), 2018 - 2030
    • 7.3.2. BPS Analysis/Market Attractiveness Analysis

8. Middle East & Africa Digital Therapeutics Market Outlook, 2018 - 2030

  • 8.1. Middle East & Africa Digital Therapeutics Market Outlook, by Application, Value (US$ Bn), 2018 - 2030
    • 8.1.1. Key Highlights
      • 8.1.1.1. Diabetes
      • 8.1.1.2. Obesity
      • 8.1.1.3. CVD
      • 8.1.1.4. Smoking Cessation
      • 8.1.1.5. CNS Diseases
      • 8.1.1.6. Others
  • 8.2. Middle East & Africa Digital Therapeutics Market Outlook, by End User, Value (US$ Bn), 2018 - 2030
    • 8.2.1. Key Highlights
      • 8.2.1.1. Patients
      • 8.2.1.2. Providers
      • 8.2.1.3. Payers
      • 8.2.1.4. Employers
      • 8.2.1.5. Other End users
    • 8.2.2. BPS Analysis/Market Attractiveness Analysis
  • 8.3. Middle East & Africa Digital Therapeutics Market Outlook, by Country, Value (US$ Bn), 2018 - 2030
    • 8.3.1. Key Highlights
      • 8.3.1.1. GCC Digital Therapeutics Market, by Application, Value (US$ Bn), 2018 - 2030
      • 8.3.1.2. GCC Digital Therapeutics Market, by End User, Value (US$ Bn), 2018 - 2030
      • 8.3.1.3. South Africa Digital Therapeutics Market, by Application, Value (US$ Bn), 2018 - 2030
      • 8.3.1.4. South Africa Digital Therapeutics Market, by End User, Value (US$ Bn), 2018 - 2030
      • 8.3.1.5. Egypt Digital Therapeutics Market, by Application, Value (US$ Bn), 2018 - 2030
      • 8.3.1.6. Egypt Digital Therapeutics Market, by End User, Value (US$ Bn), 2018 - 2030
      • 8.3.1.7. Nigeria Digital Therapeutics Market, by Application, Value (US$ Bn), 2018 - 2030
      • 8.3.1.8. Nigeria Digital Therapeutics Market, by End User, Value (US$ Bn), 2018 - 2030
      • 8.3.1.9. Rest of Middle East & Africa Digital Therapeutics Market, by Application, Value (US$ Bn), 2018 - 2030
      • 8.3.1.10. Rest of Middle East & Africa Digital Therapeutics Market, by End User, Value (US$ Bn), 2018 - 2030
    • 8.3.2. BPS Analysis/Market Attractiveness Analysis

9. Competitive Landscape

  • 9.1. Manufacturer vs End User Heatmap
  • 9.2. Company Market Share Analysis, 2022
  • 9.3. Competitive Dashboard
  • 9.4. Company Profiles
    • 9.4.1. Pear Therapeutics
      • 9.4.1.1. Company Overview
      • 9.4.1.2. Product Portfolio
      • 9.4.1.3. Financial Overview
      • 9.4.1.4. Business Strategies and Development
    • 9.4.2. Akili Interactive Labs
      • 9.4.2.1. Company Overview
      • 9.4.2.2. Product Portfolio
      • 9.4.2.3. Financial Overview
      • 9.4.2.4. Business Strategies and Development
    • 9.4.3. Click Therapeutics
      • 9.4.3.1. Company Overview
      • 9.4.3.2. Product Portfolio
      • 9.4.3.3. Financial Overview
      • 9.4.3.4. Business Strategies and Development
    • 9.4.4. Omada Health
      • 9.4.4.1. Company Overview
      • 9.4.4.2. Product Portfolio
      • 9.4.4.3. Financial Overview
      • 9.4.4.4. Business Strategies and Development
    • 9.4.5. WellDoc
      • 9.4.5.1. Company Overview
      • 9.4.5.2. Product Portfolio
      • 9.4.5.3. Financial Overview
      • 9.4.5.4. Business Strategies and Development
    • 9.4.6. Propeller Health
      • 9.4.6.1. Company Overview
      • 9.4.6.2. Product Portfolio
      • 9.4.6.3. Financial Overview
      • 9.4.6.4. Business Strategies and Development
    • 9.4.7. 2Morrow
      • 9.4.7.1. Company Overview
      • 9.4.7.2. Product Portfolio
      • 9.4.7.3. Financial Overview
      • 9.4.7.4. Business Strategies and Development
    • 9.4.8. Hinge Health
      • 9.4.8.1. Company Overview
      • 9.4.8.2. Product Portfolio
      • 9.4.8.3. Financial Overview
      • 9.4.8.4. Business Strategies and Development
    • 9.4.9. Canary Health
      • 9.4.9.1. Company Overview
      • 9.4.9.2. Product Portfolio
      • 9.4.9.3. Financial Overview
      • 9.4.9.4. Business Strategies and Development
    • 9.4.10. Better Therapeutics
      • 9.4.10.1. Company Overview
      • 9.4.10.2. Product Portfolio
      • 9.4.10.3. Financial Overview
      • 9.4.10.4. Business Strategies and Development
    • 9.4.11. Kaia Health
      • 9.4.11.1. Company Overview
      • 9.4.11.2. Product Portfolio
      • 9.4.11.3. Financial Overview
      • 9.4.11.4. Business Strategies and Development
    • 9.4.12. DarioHealth
      • 9.4.12.1. Company Overview
      • 9.4.12.2. Product Portfolio
      • 9.4.12.3. Financial Overview
      • 9.4.12.4. Business Strategies and Development
    • 9.4.13. Mindstrong Health
      • 9.4.13.1. Company Overview
      • 9.4.13.2. Product Portfolio
      • 9.4.13.3. Financial Overview
      • 9.4.13.4. Business Strategies and Development
    • 9.4.14. Biofourmis
      • 9.4.14.1. Company Overview
      • 9.4.14.2. Product Portfolio
      • 9.4.14.3. Financial Overview
      • 9.4.14.4. Business Strategies and Development
    • 9.4.15. Ginger
      • 9.4.15.1. Company Overview
      • 9.4.15.2. Product Portfolio
      • 9.4.15.3. Financial Overview
      • 9.4.15.4. Business Strategies and Development

10. Appendix

  • 10.1. Research Methodology
  • 10.2. Report Assumptions
  • 10.3. Acronyms and Abbreviations
Show more
Have a question?
Picture

Jeroen Van Heghe

Manager - EMEA

+32-2-535-7543

Picture

Christine Sirois

Manager - Americas

+1-860-674-8796

Questions? Please give us a call or visit the contact form.
Contact Us +1-866-353-3335
Hi, how can we help?
Contact us!